Cito Capital Group, LLC Abb Vie Inc. Transaction History

Cito Capital Group, LLC

$268 Million
Q3 2024

A detailed history of Cito Capital Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cito Capital Group, LLC holds 18,872 shares of ABBV stock, worth $3.37 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

18,872

Previous 20,662 8.66%

Holding current value

$3.37 Million

Previous $3.54 Million 5.16%

% of portfolio

1.39%

Previous 1.37%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $293,273 - $356,800	-1,790 Reduced 8.66%	18,872 $3.73 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $1,702 - $1,988	11 Added 0.05%	20,662 $3.54 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $1,758 - $2,003	11 Added 0.05%	20,651 $3.76 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $1,651 - $1,859	12 Added 0.06%	20,640 $3.2 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $228,438 - $264,451	1,710 Added 9.04%	20,628 $3.08 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $1,590 - $1,978	12 Added 0.06%	18,918 $2.55 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $1,446 - $1,665	10 Added 0.05%	18,906 $3.01 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $8,575 - $10,283	62 Added 0.33%	18,896 $3.05 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1,342 - $1,539	10 Added 0.05%	18,834 $2.53 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $1,376 - $1,749	10 Added 0.05%	18,824 $2.88 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $64,538 - $80,073	-489 Reduced 2.53%	18,814 $3.05 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $1,181 - $1,495	11 Added 0.06%	19,303 $2.61 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $690,323 - $783,620	-6,488 Reduced 25.17%	19,292 $2.08 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $1,157 - $1,289	11 Added 0.04%	25,780 $2.9 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $16,674 - $18,357	163 Added 0.64%	25,769 $2.79 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $56,825 - $76,721	706 Added 2.84%	25,606 $2.74 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $269,241 - $316,001	3,134 Added 14.4%	24,900 $2.18 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $136,908 - $183,203	1,866 Added 9.38%	21,766 $2.14 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $58,050 - $88,011	900 Added 4.74%	19,900 $1.52 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $62,980 - $75,720	-1,000 Reduced 5.0%	19,000 $1.44 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $131,400 - $167,960	2,000 Added 11.11%	20,000 $1.45 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $38,570 - $45,395	500 Added 2.86%	18,000 $1.45 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $133,365 - $148,260	1,500 Added 9.38%	17,500 $1.66 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $1.12 Million - $1.43 Million	16,000	16,000 $0

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cito Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cito Capital Group, LLC with notifications on news.

Account

Cito Capital Group, LLC Abb Vie Inc. Transaction History